Add like
Add dislike
Add to saved papers

Bimetallic (AuAg, AuPd and AgPd) nanoparticles supported on cellulose-based hydrogel for reusable catalysis.

Biopolymer-derived hydrogels with low-cost and sustainable features have been considered as fascinating supported materials for metal nanoparticles. Cellulose, as the most abundant biopolymer, is a renewable raw material to prepare biopolymer-derived hydrogels for catalysis. Here, a cellulose-based hydrogel is designed to load bimetallic (AuAg, AuPd and AgPd) nanoparticles. 4-Nitrophenol reduction and Suzuki-Miyaura coupling reactions are selected to evaluate and compare the catalytic performance of the resulting bimetallic nanoparticle-loaded cellulose-based composite hydrogels. The bimetallic nanocomposite hydrogels are easy to be recycled over 10 times during the catalytic experiments and possess good applicability and generality for various substrates. The catalytic activity of bimetallic nanocomposite hydrogels was compared with recent literatures. In addition, the possible catalytic mechanism is also proposed. This work is expected to give a new insight for designing and preparing bimetallic nanoparticle-based cellulose hydrogels and proves its applicability and prospect in the catalytic field.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app